Riskpilot
← Back to search
Sign in
Get full access
Vestons AB
AB
Active
Org 5567142525
Färmanstorp, 370 24
Nättraby
Other human health activities n.e.c.
· NACE 8699
Est. 2006
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other human health activities n.e.c.
/
Vestons AB
Overview
Financials
People & ownership
Related companies
Loading company…
Revenue 2024
SEK 157K
+705% vs 2023
EBITDA margin
30.5%
+153% vs 2023
Equity ratio
76.8%
Financial strength
Net profit 2024
SEK 54K
-67% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 157K
+705%
EBITDA
SEK 48K
+153%
Net profit
SEK 54K
-67%
Total assets
SEK 318K
+21%
Equity
SEK 244K
-16%
Employees
0
—
Company information
Legal name
Vestons AB
Org number
5567142525
Legal form
Aktiebolag
NACE code
8699 ·
Other human health activities n.e.c.
Founded
1 november 2006
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet ska bedriva medicinsk utveckling och konsultverksamhet inom medicinsk forskning och sjukvård samt äga och förvalta värdepapper och aktier samt därmed förenlig verksamhet.
Contact
Address
Färmanstorp, 370 24
Nättraby
Email
jbu@bth.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities n.e.c.
Companies in Karlskrona
All Sweden companies
Frequently asked questions
What is the Org number of Vestons AB?
Vestons AB is registered with Bolagsverket / SCB under Org 5567142525.
What is the revenue of Vestons AB?
Vestons AB reported revenue of SEK 157K in 2024.
Who is the chairman of Vestons AB?
Maria Del Carmen Sanmartin chairs the board of Vestons AB, in role since 2022.
Where is Vestons AB headquartered?
Vestons AB's registered address is Färmanstorp.
